J. Pingpank

Michael S. Landau, R. Brand, H. Zeh, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Percutaneous Hepatic Perfusion in Patients with Metastatic Liver Cancer: Anesthetic, Hemodynamic, and Metabolic Considerations

S. Steinberg, H. Alexander, Z. Quezado, 2008, Annals of Surgical Oncology.

Gland Size Is Associated With Changes in Gene Expression Profiles in Sporadic Parathyroid Adenomas

S. Libutti, H. Alexander, H. Alexander, 2004, Annals of Surgical Oncology.

Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei

R. Pai, H. Zeh, D. Bartlett, 2017, Annals of Surgical Oncology.

KRAS Amplification in Metastatic Colon Cancer is Associated with a History of Inflammatory Bowel Disease and May Confer Resistance to anti-EGFR Therapy

Michael S. Landau, M. Nikiforova, R. Brand, 2020, Modern Pathology.

Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma

D. Bartlett, B. Boone, K. McCluskey, 2018, Journal of surgical oncology.

Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies.

S. Libutti, B. Wood, W. Figg, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isolated Hepatic Perfusion for the Treatment of Patients With Colorectal Cancer Liver Metastases After Irinotecan-Based Therapy

S. Libutti, C. Helsabeck, H. Alexander, 2005, Annals of Surgical Oncology.

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

J. Kim, D. Davar, Amy Rose, 2021, Clinical Cancer Research.

A phase III random assignment trial comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to standard of care for patients with hepatic metastases from metastatic ocular or cutaneous melanoma.

C. Nutting, H. Alexander, M. Hughes, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting.

L. Ellis, J. Tepper, E. Van Cutsem, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isolated hepatic perfusion: treating unresectable liver metastases.

H. Alexander, J. Pingpank, J. Farma, 2006, Advances in experimental medicine and biology.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology.

L. Oñate-Ocaña, N. Petrelli, D. Shibata, 2007, Annals of surgical oncology.

6621 POSTER Percutaneous Hepatic Perfusion (PHP) With Melphalan for Patients With Unresectable Liver Metastases of Neuroendocrine Tumours (MNET) – NCT00096083

S. Libutti, B. Wood, A. Kam, 2011 .

A Pilot Feasibility Study of TNFerade™ Biologic with Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer

S. Steinberg, S. Libutti, K. Camphausen, 2011, Oncology.

Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience.

S. Libutti, H. Alexander, P. Gorden, 2009, The Journal of clinical endocrinology and metabolism.

Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases

R. Pai, D. Bartlett, A. Singhi, 2023, Annals of Surgical Oncology.

Definition and Prediction of Early Recurrence and Mortality Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: Towards Predicting Oncologic Futility Preoperatively

D. Bartlett, A. Zureikat, M. Ongchin, 2021, Annals of Surgical Oncology.

Fitbit step counts during inpatient recovery from cancer surgery as a predictor of readmission.

Dana H Bovbjerg, Amer H Zureikat, Herbert J Zeh, 2018, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion

H. Zeh, D. Bartlett, A. Zureikat, 2017, Annals of Surgical Oncology.

Oncologic Risk Stratification Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Carcinomatosis

Aaron Jaech, S. Ahrendt, H. Zeh, 2016, Annals of Surgical Oncology.

Does Obesity Affect Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Disseminated Mucinous Appendiceal Neoplasms?

H. Zeh, D. Bartlett, P. Polanco, 2014, Annals of Surgical Oncology.

Omission of Right Hemicolectomy May be Safe for Some Appendiceal Goblet Cell Adenocarcinomas: A Survival Analysis of the National Cancer Database

A. Zureikat, I. Nassour, H. Choudry, 2021, Annals of Surgical Oncology.

Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM)

H. Zeh, D. Bartlett, A. Tsung, 2018, Annals of Surgical Oncology.

Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case–Control Study

H. Zeh, D. Bartlett, N. Bahary, 2016, Annals of Surgical Oncology.

Failure to Thrive Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Causes and Consequences

D. Bartlett, A. Zureikat, M. Ongchin, 2022, Annals of Surgical Oncology.

Predischarge Prediction of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Derivation and Validation of a Risk Prediction Score

D. Bartlett, A. Zureikat, E. Kang, 2021, Annals of Surgical Oncology.

Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

D. Bartlett, B. Davies, J. Pingpank, 2016, Journal of surgical oncology.

Outcome Analysis of a Decade-Long Experience of Isolated Hepatic Perfusion for Unresectable Liver Metastases at a Single Institution

H. Zeh, D. Bartlett, A. Zureikat, 2014, Annals of surgery.

Neoadjuvant combination immunotherapy with ipilimumab (3 mg/kg or 10mg/kg) and high dose IFN-a2b in locally/regionally advanced melanoma.

Amy Rose, J. Kirkwood, H. Tawbi, 2016 .

Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.

Jeffrey E. Lee, M. Ross, D. Fraker, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeted Next-Generation Sequencing Improves the Prognostication of Patients with Disseminated Appendiceal Mucinous Neoplasms (Pseudomyxoma Peritonei)

M. Nikiforova, D. Bartlett, A. Singhi, 2023, Annals of Surgical Oncology.

S. Monaco, M. Nikiforova, R. Brand, 2019, Gut.

Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei

R. Pai, H. Zeh, D. Bartlett, 2017, Annals of Surgical Oncology.

Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM)

D. Bartlett, A. Tsung, D. Geller, 2018, Annals of Surgical Oncology.

Therapy for unresectable hepatocellular carcinoma: time for XRT?

J. Pingpank, 2004, Cancer journal.